Clariant signs agreements to divest 50 % stake in Scientific Design joint venture to SABIC

MUTTENZ, FEBRUARY 2, 2022

Clariant, a focused, sustainable and innovative specialty chemicals company, has signed definitive agreements to divest its 50 % stake in the joint venture which owns Scientific Design Company Inc. to its long-term joint venture partner, SABIC. SABIC is executing a call option raised in 2015 to acquire this stake, originally purchased by Süd-Chemie AG in 2003 and acquired by Clariant in 2011, pursuant to a change-of-control clause in the Joint Venture agreement.

Clariant reports a book value for the 50 % stake in Scientific Design Company Inc. of CHF 108 million as of 31 December 2020. Both Clariant and SABIC completed a comprehensive, arms-length due diligence process to value Scientific Design at USD 260 million and Clariant’s 50 % share at USD 130 million. Together with a profit-sharing agreement beginning on January 1, 2021 until the closing of the transaction, this represents an attractive valuation for Clariant’s 50 % stake at around 12 times Scientific Design’s 2021 expected EBITDA, assuming a mid-2022 closing. The final amount is payable at closing, which is subject to the receipt of the required regulatory approvals. The closing is expected to take place in mid-2022.

In 2020, Scientific Design Company Inc. generated sales of CHF 121 million. Scientific Design Company Inc., headquartered in Little Ferry, New Jersey, United States, is present in the development, licensing and catalyst supply of proprietary processes for the production of ethylene oxide (EO), ethylene glycol (EO/EG), bio-ethylene, bio-EO, bio-EG, EO derivatives, polyols and maleic anhydride. In addition to these technologies, Scientific Design Company Inc. produces proprietary catalysts and equipment for use in their own and other industrial processes.

CORPORATE MEDIA RELATIONS   Jochen DubielPhone +41 61 469 63 63jochen.dubiel@clariant.com   Anne MaierPhone +41 61 469 63 63anne.maier@clariant.com Ellese GolderPhone +41 61 469 63 63ellese.golder@clariant.com   INVESTOR RELATIONS   Andreas Schwarzwälder Phone +41 61 469 63 73andreas.schwarzwaelder@clariant.com   Maria IvekPhone +41 61 469 63 73maria.ivek@clariant.com   Alexander KambPhone +41 61 469 63 73alexander.kamb@clariant.com
Follow us on Twitter, Facebook, LinkedIn, Instagram.   This media release contains certain statements that are neither reported financial results nor other historical information. This document also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant’s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors; the Company’s ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.   www.clariant.com     Clariant is a focused, sustainable and innovative specialty chemical company based in Muttenz near Basel/Switzerland. On 31 December 2020, the company employed a total workforce of 13 235. In the financial year 2020, Clariant recorded sales of CHF 3.860 billion for its continuing businesses. The company reports in three business areas: Care Chemicals, Catalysis and Natural Resources. Clariant’s corporate strategy is led by the overarching purpose of ‘Greater chemistry – between people and planet’ and reflects the importance of connecting customer focus, innovation, sustainability, and people.

 

Attachments

  • Clariant Media Release_ScientificDesign stake sold_20220202 EN
  • Clariant Media Release_ScientificDesign stake sold_20220202 DE
Clariant (LSE:0QJS)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more Clariant Charts.
Clariant (LSE:0QJS)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Clariant Charts.